Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Oxidative stress and cardiac hypertrophy: a review.

Maulik SK, Kumar S.

Toxicol Mech Methods. 2012 Jun;22(5):359-66. doi: 10.3109/15376516.2012.666650. Epub 2012 Mar 20. Review.

PMID:
22394344
2.

Desmodium gangeticum (Linn.) DC. exhibits antihypertrophic effect in isoproterenol-induced cardiomyoblasts via amelioration of oxidative stress and mitochondrial alterations.

Sankar V, Pangayarselvi B, Prathapan A, Raghu KG.

J Cardiovasc Pharmacol. 2013 Jan;61(1):23-34. doi: 10.1097/FJC.0b013e3182756ad3.

PMID:
23052030
3.

Oxidative stress and heart failure.

Tsutsui H, Kinugawa S, Matsushima S.

Am J Physiol Heart Circ Physiol. 2011 Dec;301(6):H2181-90. doi: 10.1152/ajpheart.00554.2011. Epub 2011 Sep 23. Review.

4.

NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure.

Murdoch CE, Zhang M, Cave AC, Shah AM.

Cardiovasc Res. 2006 Jul 15;71(2):208-15. Epub 2006 Mar 27. Review.

PMID:
16631149
5.

Allicin protects against cardiac hypertrophy and fibrosis via attenuating reactive oxygen species-dependent signaling pathways.

Liu C, Cao F, Tang QZ, Yan L, Dong YG, Zhu LH, Wang L, Bian ZY, Li H.

J Nutr Biochem. 2010 Dec;21(12):1238-50. doi: 10.1016/j.jnutbio.2009.11.001. Epub 2010 Feb 25.

PMID:
20185286
6.

Oxidative stress and heart failure.

Byrne JA, Grieve DJ, Cave AC, Shah AM.

Arch Mal Coeur Vaiss. 2003 Mar;96(3):214-21. Review.

PMID:
12722552
7.

Involvement of NADPH oxidases in cardiac remodelling and heart failure.

Sirker A, Zhang M, Murdoch C, Shah AM.

Am J Nephrol. 2007;27(6):649-60. Epub 2007 Sep 27. Review.

8.

Additive beneficial effects of amlodipine and atorvastatin in reversing advanced cardiac hypertrophy in elderly spontaneously hypertensive rats.

Lu JC, Cui W, Zhang HL, Liu F, Han M, Liu DM, Yin HN, Zhang K, Du J.

Clin Exp Pharmacol Physiol. 2009 Nov;36(11):1110-9. doi: 10.1111/j.1440-1681.2009.05198.x. Epub 2009 Apr 27.

PMID:
19413592
9.

Molecular mechanisms of hypertension--reactive oxygen species and antioxidants: a basic science update for the clinician.

Montezano AC, Touyz RM.

Can J Cardiol. 2012 May;28(3):288-95. doi: 10.1016/j.cjca.2012.01.017. Epub 2012 Mar 23. Review.

PMID:
22445098
10.

Right-ventricular failure is associated with increased mitochondrial complex II activity and production of reactive oxygen species.

Redout EM, Wagner MJ, Zuidwijk MJ, Boer C, Musters RJ, van Hardeveld C, Paulus WJ, Simonides WS.

Cardiovasc Res. 2007 Sep 1;75(4):770-81. Epub 2007 May 17.

PMID:
17582388
11.

Protective effect of Boerhaavia diffusa L. against mitochondrial dysfunction in angiotensin II induced hypertrophy in H9c2 cardiomyoblast cells.

Prathapan A, Vineetha VP, Raghu KG.

PLoS One. 2014 Apr 30;9(4):e96220. doi: 10.1371/journal.pone.0096220. eCollection 2014.

12.

Atheroprotective effects of antioxidants through inhibition of mitogen-activated protein kinases.

Kyaw M, Yoshizumi M, Tsuchiya K, Izawa Y, Kanematsu Y, Tamaki T.

Acta Pharmacol Sin. 2004 Aug;25(8):977-85. Review.

13.

Loss of NOX2 (gp91phox) prevents oxidative stress and progression to advanced heart failure.

Parajuli N, Patel VB, Wang W, Basu R, Oudit GY.

Clin Sci (Lond). 2014 Sep;127(5):331-40. doi: 10.1042/CS20130787.

PMID:
24624929
14.

Redox signaling in hypertension.

Paravicini TM, Touyz RM.

Cardiovasc Res. 2006 Jul 15;71(2):247-58. Epub 2006 May 9. Review.

PMID:
16765337
15.

NADPH oxidase and cardiac failure.

Kuroda J, Sadoshima J.

J Cardiovasc Transl Res. 2010 Aug;3(4):314-20. doi: 10.1007/s12265-010-9184-8. Epub 2010 Mar 31. Review.

16.

Apocynin attenuates pressure overload-induced cardiac hypertrophy in rats by reducing levels of reactive oxygen species.

Liu J, Zhou J, An W, Lin Y, Yang Y, Zang W.

Can J Physiol Pharmacol. 2010 Jul;88(7):745-52. doi: 10.1139/y10-063.

PMID:
20651822
17.

Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure.

Sorescu D, Griendling KK.

Congest Heart Fail. 2002 May-Jun;8(3):132-40. Review.

18.

Mitochondrial oxidative stress and dysfunction in myocardial remodelling.

Tsutsui H, Kinugawa S, Matsushima S.

Cardiovasc Res. 2009 Feb 15;81(3):449-56. doi: 10.1093/cvr/cvn280. Epub 2008 Oct 14. Review.

PMID:
18854381
19.
20.

Role of AT1 receptor in isoproterenol-induced cardiac hypertrophy and oxidative stress in mice.

Zhang GX, Ohmori K, Nagai Y, Fujisawa Y, Nishiyama A, Abe Y, Kimura S.

J Mol Cell Cardiol. 2007 Apr;42(4):804-11. Epub 2007 Feb 3.

PMID:
17350036

Supplemental Content

Support Center